Egyptian Rheumatology and Rehabilitation

metrics 2024

Transforming musculoskeletal care with groundbreaking insights.

Introduction

Egyptian Rheumatology and Rehabilitation is a distinguished open-access journal published by SpringerNature, dedicated to the vital field of rheumatology and rehabilitation. With an E-ISSN of 2090-3235 and a commitment to disseminating high-quality research, this journal serves as a platform for researchers, clinicians, and healthcare professionals to share innovative findings and enhance patient care in musculoskeletal disorders and related conditions. Since its transition to open access in 2013, the journal has prioritized accessibility, allowing a wider audience to engage with groundbreaking studies and clinical insights. By fostering a collaborative environment for knowledge exchange, Egyptian Rheumatology and Rehabilitation plays a crucial role in advancing the understanding of rheumatic diseases and improving rehabilitation strategies. The journal's commitment to quality and relevance in the evolving landscape of rheumatology makes it an invaluable resource for those pursuing excellence in research and practice.

Metrics 2024

SCIMAGO Journal Rank-
Journal Impact Factor0.80
Journal Impact Factor (5 years)-
H-Index-
Journal IF Without Self0.80
Eigen Factor0.00
Normal Eigen Factor0.06
Influence-
Immediacy Index0.20
Cited Half Life3.00
Citing Half Life9.10
JCI0.21
Total Documents-
WOS Total Citations198
SCIMAGO Total Citations-
SCIMAGO SELF Citations-
Scopus Journal Rank-
Cites / Document (2 Years)-
Cites / Document (3 Years)-
Cites / Document (4 Years)-

Metrics History

Rank 2024

IF (Web Of Science)

RHEUMATOLOGY
Rank 53/57
Percentile 7.90
Quartile Q4

JCI (Web Of Science)

RHEUMATOLOGY
Rank 52/57
Percentile 8.77
Quartile Q4

Quartile History

Similar Journals

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Shaping the Future of Rheumatology Care
Publisher: ELSEVIER SCI LTDISSN: 1521-6942Frequency: 4 issues/year

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, published by Elsevier, stands as a premier journal in the field of rheumatology, holding a prestigious Q1 ranking in both Medicine (miscellaneous) and Rheumatology categories as of 2023. With an ISSN of 1521-6942 and an E-ISSN of 1521-1770, the journal is dedicated to advancing clinical knowledge and practice through the dissemination of high-quality, peer-reviewed research. Since its inception in 1995, this journal has provided a platform for researchers, clinicians, and healthcare providers to share significant advancements, best practices, and innovative insights that shape the standards of care in rheumatology. The commitment to open access publishing reflects its mission to broaden the reach of critical research findings, ensuring that professionals across the globe can access valuable information in this vital field. The journal's impressive Scopus ranking, positioned at #10 out of 73 in Medicine-Rheumatology, alongside its notable impact factor, underscores its importance and influence in guiding clinical practice and policy in rheumatologic conditions. By engaging with this journal, readers can stay informed about emerging trends and evidence-based strategies that are crucial for improving patient outcomes.

RMD Open

Fostering collaboration for breakthrough discoveries.
Publisher: BMJ PUBLISHING GROUPISSN: 2056-5933Frequency: 2 issues/year

RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.

Journal of Orthopaedics Trauma and Rehabilitation

Transforming the landscape of orthopaedic research.
Publisher: SAGE PUBLICATIONS LTDISSN: 2210-4917Frequency: 2 issues/year

Journal of Orthopaedics Trauma and Rehabilitation, published by SAGE Publications Ltd, is a premier platform dedicated to the interdisciplinary field of orthopaedics, trauma, and rehabilitation. Since its transition to Open Access in 2016, it has significantly enhanced the accessibility of vital research, catering to an international audience of researchers, healthcare professionals, and students. Based in the Netherlands, this journal provides a comprehensive look at the latest advancements and challenges in orthopaedics and rehabilitation, enriching the academic landscape with its focus on innovative treatment methodologies. With a publication history converging from 2010 to 2024, the journal is categorized in Q4 for Orthopedics and Sports Medicine, as well as for Physical Therapy, Sports Therapy, and Rehabilitation, highlighting its relevance in these fields. Despite its current ranking of #124/161 in Rehabilitation and #270/321 in Orthopedics within Scopus, the Journal of Orthopaedics Trauma and Rehabilitation remains a vital resource for contributing authors seeking to share their findings and advance the body of knowledge in these important specialties.

Current Rheumatology Reviews

Shaping the future of rheumatology through rigorous reviews.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3971Frequency: 3 issues/year

Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.

RHEUMATOLOGY INTERNATIONAL

Empowering researchers and clinicians with vital insights.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

Current Treatment Options in Rheumatology

Exploring cutting-edge strategies for effective rheumatic disease management.
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Treatment Options in Rheumatology, published by SPRINGERNATURE, is a pivotal journal focused on advancing the field of rheumatology through the dissemination of cutting-edge research and comprehensive reviews. With an emphasis on current therapeutic strategies, this journal aims to provide healthcare professionals, researchers, and students with up-to-date information on the latest treatment modalities for rheumatic diseases. Although it operates under a subscription model, it offers a platform for sharing significant findings that can influence clinical practice and policy within the field of rheumatology. By promoting insightful discussions and collaborations, Current Treatment Options in Rheumatology plays a crucial role in shaping the future of rheumatic disease management and improving patient outcomes.

Musculoskeletal Care

Innovating Therapies for Enhanced Patient Outcomes
Publisher: WILEYISSN: 1478-2189Frequency: 4 issues/year

Musculoskeletal Care is a prestigious journal published by WILEY, focusing on the multidisciplinary field of musculoskeletal health. With its ISSN 1478-2189 and E-ISSN 1557-0681, the journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to the study and treatment of musculoskeletal disorders. Since its inception in 2003, it has maintained a strong reputation, achieving a Q1 ranking in Chiropractics and notable placements in other relevant categories, including Nursing and Orthopedics. The journal emphasizes the importance of evidence-based practices, innovative therapies, and collaborative research, making it essential reading for those involved in rehabilitation, sports medicine, and rheumatology. Although not an open-access journal, it remains widely accessible through academic institutions and professional organizations, contributing significantly to the ongoing discourse in musculoskeletal care and enhancing the quality of care provided to patients worldwide.

Arthritis & Rheumatology

Empowering Global Collaboration in Rheumatology
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Orthopadie

Transforming treatment strategies with cutting-edge research.
Publisher: SPRINGERISSN: 2731-7145Frequency: 12 issues/year

Orthopadie is a pivotal journal in the field of orthopedics and sports medicine, published by SPRINGER. With its ISSN 2731-7145 and E-ISSN 2731-7153, this journal serves as a key resource for researchers, professionals, and students looking to stay updated with the latest advancements in orthopedic practices and sports-related injuries. Based in Germany, it reflects a commitment to fostering rigorous academic dialogue and innovative research from 2022 to 2024. The journal has achieved a respectable Q3 category ranking in Orthopedics and Sports Medicine for 2023, positioning it within the competitive landscape of its field, ranking #214 out of 321 in *Scopus* for its subject area. While currently not offering open access options, the journal remains dedicated to disseminating vital findings that enhance understanding and treatment within the orthopedic community. With a growing impact within the scientific community, Orthopadie is poised to become an essential platform for pioneering research and knowledge in orthopedics.

RHEUMATOLOGY

Advancing the Frontiers of Rheumatic Disease Research
Publisher: OXFORD UNIV PRESSISSN: 1462-0324Frequency: 12 issues/year

RHEUMATOLOGY, published by Oxford University Press, is a leading journal in the fields of Pharmacology and Rheumatology, recognized for its significant contribution to advancing the understanding and treatment of rheumatic diseases. With an impressive impact factor and ranking within the top quartiles for both medical pharmacology and rheumatology, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals. The journal spans an extensive publication history, with contributions from 1952 to 1995 and from 1998 to 2024, reflecting its enduring commitment to disseminating high-quality research. The Open Access option allows for broader dissemination of knowledge, enhancing the visibility of groundbreaking studies. Positioned in the United Kingdom, RHEUMATOLOGY not only offers valuable insights into the latest therapeutic advancements and clinical guidelines but also fosters collaboration across disciplines, ensuring that practitioners stay at the forefront of innovation in the management of rheumatic conditions.